Full Text View
Tabular View
No Study Results Posted
Related Studies
Calfactant for Direct Acute Respiratory Distress Syndrome (CARDS)
This study has been terminated.
( Expected mortality rates in placebo and treatment groups lower than predicted )
Study NCT00682500   Information provided by Pneuma Pharmaceuticals Incorporated

First Received on May 20, 2008.   Last Updated on July 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Acute Lung Injury
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
More general conditions related to this trial
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Calfactant
Room Air (placebo)
More general drug interventions related to this trial
Pharmacologic Actions
Pulmonary Surfactants
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pneuma Pharmaceuticals Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services